The Trump administration announced deals Thursday with Eli Lilly and Novo Nordisk to slash the prices of their weight-loss ...

Trump administration strikes deal with Novo Nordisk and Eli Lilly to slash weight-loss drug costs. Wegovy starting doses drop ...

Pfizer and Novo Nordisk are locked in a bidding war for biotech firm Metsera as the pharmaceutical giants seek to augment ...

President Trump will announce concessions from Eli Lilly and Novo Nordisk that would lower the price of some of the companies ...

A small study helps explain why some people taking Wegovy and similar weight-loss drugs cut back on alcohol, offering insight ...

Meghan Trainor still doesn’t care what the haters have to say. The pop star, 31, clapped back at people who have criticized ...

Investing in pharmaceutical companies with diversified revenue bases and strong R&D pipelines could be a lucrative strategy.

The Trump administration is nearing deals with drugmakers Eli Lilly and Novo Nordisk to offer some of their obesity drugs to consumers for as low as $149 per month, according to two people familiar ...

Eli Lilly and rival drugmaker Novo Nordisk are the leading companies in the GLP-1 space, but others are emerging. Among them ...

People looking to lose weight and lower their blood sugar may someday be able to get a single injection that turns their cells into tiny factories that churn out a protein that is essentially the ...

Nestlé is embracing the GLP-1 revolution with new weight management innovations, academic partnerships, and products tailored to users of drugs like Wegovy and Ozempic. Discover how the food industry ...